West Pharmaceutical
640 hedge funds and large institutions have $24.7B invested in West Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 105 funds opening new positions, 222 increasing their positions, 215 reducing their positions, and 51 closing their positions.
106% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 51
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
28% more capital invested
Capital invested by funds: $19.3B → $24.7B (+$5.48B)
8% more funds holding
Funds holding: 590 → 640 (+50)
3% more repeat investments, than reductions
Existing positions increased: 222 | Existing positions reduced: 215
0.82% more ownership
Funds ownership: 93.04% → 93.85% (+0.82%)
47% less call options, than puts
Call options by funds: $28.2M | Put options by funds: $53.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$117M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$107M |
| 3 |
Morgan Stanley
New York
|
+$82.8M |
| 4 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$65.8M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$63.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$135M |
| 2 |
Goldman Sachs
New York
|
-$107M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$98.5M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$85.6M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$63.9M |
WST Hedge Fund Activity: Q2 2021 in Review
640 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2021, worth a combined $24.7B — up 28% from $19.3B a quarter earlier.
Buyers outnumbered sellers: 105 funds opened new WST positions and 51 closed out — a net gain of 54 holders — while 222 added to existing stakes and 215 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $117M. The largest seller was Invesco, cutting an estimated $135M.
- 640 institutional investors held West Pharmaceutical (WST) as of Q2 2021, up from 590 in Q1 2021.
- Funds reported $24.7B of West Pharmaceutical stock for Q2 2021, up 28% quarter-over-quarter.
- 105 funds opened new West Pharmaceutical positions in Q2 2021 and 51 closed out, a net change of +54 holders.
- The largest West Pharmaceutical buyer in Q2 2021 was Fidelity Investments, an estimated $117M added.
- The largest West Pharmaceutical seller in Q2 2021 was Invesco, an estimated $135M sold.
Based on aggregated 13F filings for Q2 2021.